Gaviscon Double Action Mint Flavour Chewable Tablets

Gaviscon is a prominent pharmaceutical brand specializing in the relief of heartburn and acid indigestion. Originally developed by Reckitt & Colman (now Reckitt) in the United Kingdom, the brand has become one of the most recognizable gastrointestinal treatments globally. The product showcased is the Double Action variety, which is formulated with sodium alginate, sodium bicarbonate, and calcium carbonate to both neutralize stomach acid and form a protective barrier.

Manufacturing primarily takes place in the United Kingdom, specifically at Reckitt’s major production site in Hull, which serves as a global hub for the brand’s liquid and tablet formulations. However, because Gaviscon is marketed internationally, local manufacturing or packaging may occur in other regions such as Europe, Australasia, and Asia to meet regional demand.

In terms of ownership, Gaviscon remains a flagship brand of Reckitt (formerly Reckitt Benckiser), a British multinational consumer goods company. While GlaxoSmithKline (GSK) historically held rights to the brand in the United States, Reckitt manages the brand across the majority of global markets, including the UK, Europe, and India. The brand continues to lead the category through ongoing innovation in delivery formats and fast-acting formulations.